Panbiotic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Panbiotic
Panbiotic Private Limited (PPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 May 2016 (Eight years and nine months 11 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Rauniyar, Vishal Rauniyar, and Tusharbhai Sonani serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24296MH2016PTC281014
- Company No.
281014
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Panbiotic Private Limited offer?
Panbiotic Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antibiotic Tablets & Capsules, Azithromycin Tablets, Pharmaceutical Syrup, Dry Syrups, Antibiotic Injection, Ceftriaxone Injection.
Who are the key members and board of directors at Panbiotic?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Rauniyar  | Director | 13-May-2016 | Current |
| Vishal Rauniyar | Director | 13-May-2016 | Current |
| Tusharbhai Sonani | Additional Director | 21-Feb-2024 | Current |
Financial Performance of Panbiotic.
Panbiotic Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Panbiotic?
In 2017, Panbiotic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aeon Procare Private LimitedVikas Rauniyar is a mutual person
Medvish Value Space Healthcare LlpVikas Rauniyar and Vishal Rauniyar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Panbiotic?
Unlock and access historical data on people associated with Panbiotic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panbiotic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panbiotic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.